Overview

A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

Status:
Completed

Trial end date:
2021-04-30

Target enrollment:

Participant gender:

Summary

A Phase I Clinical Trial for BAT5906(single-dose;for injection) on Safety and Pharmacokinetics for Patients with Age-related macular degeneration.

Phase:

Phase 1

Details

Lead Sponsor:

Bio-Thera Solutions